Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial
British Journal of Anaesthesia · 2025-08 · 135 (2) · 382-389
DOI: 10.1016/j.bja.2025.04.045 ↗Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift British Journal of Anaesthesia, 2025-08. Verfasst von Małgorzata Reysner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: mdomagalska@ump.edu.pl. Hauptthemen laut MEDLINE: Chronic Pain, Ethanol, Nerve Block, Osteoarthritis, Hip. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences.
Abstract (Originalsprache)
BACKGROUND: Chronic hip pain from osteoarthritis greatly diminishes quality of life, and standard treatments often fail to provide sufficient relief. Ultrasound-guided pericapsular nerve group (PENG) neurolysis using ethanol is a minimally invasive technique that may provide extended analgesia. This study evaluated the efficacy and safety of ultrasound-guided 95% ethanol neurolysis of the PENG compared with a sham procedure in patients with chronic hip pain. METHODS: This double-blinded, single-centre, RCT included 100 patients (median age: 82 yr [IQR 74-89]; 49% male) with chronic hip pain unresponsive to conservative treatments. Participants were assigned to either ethanol neurolysis (n=50) or a sham procedure (n=50). The primary outcome was pain intensity (numeric rating scale [NRS]) assessed at 7 days, 30 days, 3 months, and 6 months. Secondary outcomes included opioid consumption (oral morphine equivalents), quality of life (EQ-5D-5L), and neurological deficits. RESULTS: Ethanol neurolysis significantly reduced NRS scores at all follow-ups (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: mdomagalska@ump.edu.pl.
- Department of Palliative Medicine, Poznan University of Medical Sciences, Poznan, Poland.
- Department of Forensic Medicine, Institute of Medical Sciences Collegium Medicum, University of Zielona Góra, Zielona Góra, Poland.
- Department of Organization and Management in Health Care, Poznan University of Medical Sciences, Poznan, Poland.
Förderung
- Poznan University of Medical Sciences
Zitieren
APA
Reysner, M., Reysner, T., Kowalski, G., Mularski, A., Daroszewski, P., & Wieczorowska-Tobis, K. (2025). Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial. British Journal of Anaesthesia, 135(2), 382-389. https://doi.org/10.1016/j.bja.2025.04.045
Vancouver
Reysner M, Reysner T, Kowalski G, Mularski A, Daroszewski P, Wieczorowska-Tobis K. Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial. British Journal of Anaesthesia. 2025;135(2):382-389. doi:10.1016/j.bja.2025.04.045
BibTeX
@article{Reysner2025,
author = {Reysner, Małgorzata and Reysner, Tomasz and Kowalski, Grzegorz and Mularski, Aleksander and Daroszewski, Przemysław and Wieczorowska-Tobis, Katarzyna},
title = {Chemical ablation of pericapsular nerve group with 95% ethanol for pain relief and quality of life in patients with hip osteoarthritis: a prospective, double-blinded, randomised, controlled trial},
journal = {British Journal of Anaesthesia},
year = {2025},
volume = {135},
number = {2},
pages = {382--389},
doi = {10.1016/j.bja.2025.04.045}
}
EUVIMED